Interviews

Biobanking – Creating a Collaborative Approach between Academia & Industry

Biobanking – Creating a Collaborative Approach between Academia & Industry

In this interview Arndt Schmitz, Head of Research Biobank, Bayer Pharma AG, speaks about creating a collaborative approach between academia and industry, the associated hurdles when technology is transferred from academia to industry and measuring successful collaboration in biobanking.
Biobanking - Evaluating the Benefits of Public-Private Partnerships

Biobanking - Evaluating the Benefits of Public-Private Partnerships

Cutting edge research as well as further innovations in the life science industry will strongly depend on transnational access to high quality human biological data derived from samples, and to the associated medical information, all of which must be accessible to both academia and industry in an efficient and secure manner. In this interview Heli Salimen-Mankonen, Research Director, Auria Biobank, speaks about forming and sustaining public-private partnerships and the evaluating the benefits of this collaboration.
Compound Management: The Ever-Changing Role of CROs

Compound Management: The Ever-Changing Role of CROs

In this interview, Rose Gonzales, who is a director at Pfizer, joins us to talk about the ever-changing role of CROs as well as the effective utilisation of strong compound management within the drug discovery process.